In this week’s New England Journal of Medicine Dr. Lisa Rosenbaum uses digital adherence monitoring to offer an overview of the complexities surrounding medication adherence. In Swallowing a Spy — The Potential Uses of Digital Adherence Monitoring she concludes that technology won’t make up for what doctors don’t have the time to do: For those of us who struggle, ... Continue Reading about 3 Points on Potential Uses of Digital Adherence Monitoring
I hear less about quantified self these days. 6-8 years ago at tech/digital meetings it was the stuff of panels. Not so much any more. Talking about quantified self as a thing is odd because many of us are measuring things about ourselves. Enough to make it less of a novelty than it once was. When cell phones were new we measured how many people had them. When ... Continue Reading about Quantified Self: Dead or Just Part of the Background?
It’s been an interesting week to watch the news surrounding the Apple Watch. The FDA approved the Kardia Band - a new ECG sensor for the Apple Watch that allows the recording of a single-lead ECG with the capture of conditions such as atrial fibrillation (AF). Apple also announced its entry into cardiac research with the Apple Heart Study. In partnership with ... Continue Reading about Kardia Band for Apple Watch – 4 Lessons From the Hype Cycle
A JAMA article this week proposes the a new specialty, the medical virtualist. But the suggestion that the virtual connection of doctors and patients will be restricted enough to be a medical specialty is shortsighted. The medium does not define the doctor Because the medium doesn’t define the doctor. In fact, it should be the other way around. Communication ... Continue Reading about Medical Virtualist – A Specialty with a Tenuous Future
Building on their long line of increasingly amped-up step counters, Fitbit announced the release of its latest product, the Ionic. Coming in at $300, the Fitbit Ionic brings all the usual suspects when it comes to smart watch features: 4 days of battery life, GPS, music, mobile payment, and a small handful of ‘apps.’ The Ionic releases with a dormant sPO2 meter which ... Continue Reading about Ionic – Fitbit’s Expensive Step Counter
Chrissy Farr in Technology Review (Can Digital Therapeutics Be as Good as Drugs?) this week pulls back the curtain on digital therapeutics, Silicon Valley’s latest angle in health. Digital therapeutics, or “digiceuticals,” as some call them, have become a Holy Grail in some quarters of Silicon Valley, where investors see the chance to deliver medicine through your ... Continue Reading about Digital Therapeutics – The Third Phase of Medicine